China SXT Pharmaceuticals (SXTC) Shares Outstanding (Weighted Average) (2018 - 2025)
Historic Shares Outstanding (Weighted Average) for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $116.0 million.
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) fell 9640.93% to $116.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.0 million, marking a year-over-year decrease of 9640.93%. This contributed to the annual value of $41591.0 for FY2022, which is 9421.99% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Shares Outstanding (Weighted Average) of $116.0 million as of Q3 2025, which was down 9640.93% from $3.2 billion recorded in Q3 2024.
- China SXT Pharmaceuticals' 5-year Shares Outstanding (Weighted Average) high stood at $3.2 billion for Q3 2024, and its period low was $41591.0 during Q1 2022.
- In the last 5 years, China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) had a median value of $116.0 million in 2025 and averaged $675.6 million.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) skyrocketed by 530277.65% in 2021, and later crashed by 9640.93% in 2025.
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $777.5 million in 2021, then tumbled by 86.84% to $102.3 million in 2022, then skyrocketed by 390.12% to $501.5 million in 2023, then surged by 544.38% to $3.2 billion in 2024, then plummeted by 96.41% to $116.0 million in 2025.
- Its last three reported values are $116.0 million in Q3 2025, $3.2 billion for Q3 2024, and $501.5 million during Q3 2023.